BTF3L4P inhibitors are a class of chemical compounds that specifically target and inhibit the activity of BTF3L4P, a pseudogene variant of the BTF3 (Basic Transcription Factor 3) family. Pseudogenes, like BTF3L4P, are genomic sequences similar to their functional counterparts but are typically non-coding or non-functional under normal conditions. However, pseudogenes can still exert regulatory effects, particularly through their interactions with gene expression and RNA interference pathways. BTF3L4P may influence the transcriptional processes by acting as a decoy or by modulating the availability of regulatory proteins or RNAs associated with the BTF3 family. Inhibition of BTF3L4P activity disrupts these regulatory interactions, potentially affecting the transcriptional network by altering the balance between active genes and their pseudogene counterparts.
BTF3L4P inhibitors are valuable tools for researchers exploring the often-overlooked roles of pseudogenes in cellular regulation. Inhibiting BTF3L4P allows scientists to study the complex interactions between pseudogenes and their functional relatives, offering insights into how these genetic elements contribute to gene expression regulation. The study of BTF3L4P inhibitors sheds light on how pseudogenes like BTF3L4P might interact with RNA molecules, transcription factors, or other cellular components, thus influencing broader transcriptional activities. Furthermore, understanding the inhibition of pseudogene activity can help reveal how these sequences impact overall genomic stability and cellular responses to environmental or internal signals. BTF3L4P inhibitors enable researchers to investigate the subtle yet significant contributions pseudogenes make in regulating genetic networks, thus advancing our knowledge of gene regulation and the complexity of the cellular transcriptome.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates into DNA, hindering RNA polymerase action and potentially decreasing transcription of various genes. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
It blocks the translocation step in eukaryotic protein synthesis, which might reduce the production of many proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway, which is involved in the regulation of protein synthesis and could downregulate the synthesis of proteins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, it may alter gene expression patterns, including those not yet fully characterized. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase, this compound can change chromatin structure and potentially decrease gene transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Targets RNA polymerase II specifically, affecting the synthesis of mRNA, which may decrease the levels of various proteins. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, which could affect nucleotide synthesis and subsequently RNA synthesis. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Disrupts protein synthesis by targeting peptidyl transferase activity on ribosomes, likely decreasing the translation of proteins. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits topoisomerase I, essential for DNA replication and transcription, potentially affecting gene expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Acts selectively on RNA polymerase II, which would decrease the transcription of a wide array of genes. | ||||||